Machine learning meets drug development

InVivo AI is building the next generation of computational drug discovery

Request a Demo

By improving the generation, screening, and optimization of molecules in the earliest phases of drug development, we hope to increase clinical success rates while saving time and money in bringing new therapies to patients.

What we do

We integrate previously unused information about a compound’s molecular structure, biological target(s), and associated pathways with a series of deep neural networks and novel transfer-learning algorithms to provide a differentiated platform for generative drug design, virtual screening, and AI-driven lead optimization.

How we do it

By aggregating data across a combination of public, private, and academic databases, our machine learning team has access to millions of data points for drugs, drug targets, and preclinical and clinical stage outcomes.

Our mission is to increase clinical success rates while saving time and money in bringing new therapies to patients.

With Support From

CenTech
Techstars AI
FounderFuel
Front Row Ventures
IVADO
McGill Dobson Centre for Entrepreneurship
Creative Destruction Lab
Real Ventures

Contact us

Drop us a note

We're located in downtown Montreal, one of North America's most livable cities. Working out of Montreal’s vibrant university and life-sciences ecosystems, we benefit from privileged relationships with some of the world’s leading players in artificial intelligence and biotech.

+1-647-628-5860
hello@invivoai.com